JP2021521230A5 - - Google Patents
Info
- Publication number
- JP2021521230A5 JP2021521230A5 JP2020556885A JP2020556885A JP2021521230A5 JP 2021521230 A5 JP2021521230 A5 JP 2021521230A5 JP 2020556885 A JP2020556885 A JP 2020556885A JP 2020556885 A JP2020556885 A JP 2020556885A JP 2021521230 A5 JP2021521230 A5 JP 2021521230A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- insulin
- chain
- seq
- amino acid
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862658372P | 2018-04-16 | 2018-04-16 | |
| US62/658,372 | 2018-04-16 | ||
| PCT/US2019/027484 WO2019204206A1 (en) | 2018-04-16 | 2019-04-15 | Glucose-responsive insulin |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021521230A JP2021521230A (ja) | 2021-08-26 |
| JP2021521230A5 true JP2021521230A5 (https=) | 2022-04-25 |
| JPWO2019204206A5 JPWO2019204206A5 (https=) | 2022-04-25 |
Family
ID=68239869
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020556885A Pending JP2021521230A (ja) | 2018-04-16 | 2019-04-15 | グルコース応答性インスリン |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20210214412A1 (https=) |
| EP (1) | EP3781147A4 (https=) |
| JP (1) | JP2021521230A (https=) |
| KR (1) | KR20210005630A (https=) |
| CN (1) | CN112423741A (https=) |
| AU (1) | AU2019255611A1 (https=) |
| CA (1) | CA3097359A1 (https=) |
| WO (1) | WO2019204206A1 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016179568A1 (en) | 2015-05-06 | 2016-11-10 | Protomer Technologies, Inc. | Glucose responsive insulins |
| EP3939605A1 (en) | 2016-12-09 | 2022-01-19 | Akston Biosciences Corporation | Insulin-fc fusions and methods of use |
| WO2019092125A1 (en) | 2017-11-09 | 2019-05-16 | Novo Nordisk A/S | Glucose-sensitive albumin-binding derivatives |
| US11267862B2 (en) | 2018-06-29 | 2022-03-08 | Akston Biosciences Corporation | Ultra-long acting insulin-Fc fusion proteins and methods of use |
| KR20210029210A (ko) | 2018-06-29 | 2021-03-15 | 악스톤 바이오사이언시스 코퍼레이션 | 초장기 작용 인슐린-fc 융합 단백질 및 사용 방법 |
| EP3946363A2 (en) * | 2019-03-29 | 2022-02-09 | Novo Nordisk A/S | Glucose sensitive insulin derivatives |
| JP7834341B2 (ja) * | 2019-07-31 | 2026-03-24 | シーエス ファーマシューティカルズ エルエルシー | グルコース調節型立体配座スイッチを有するインスリン類似体 |
| FI4073098T3 (fi) | 2019-12-19 | 2023-11-15 | Akston Biosciences Corp | Ultrapitkävaikutteiset insuliini-Fc-fuusioproteiinit ja niiden käyttömenetelmät |
| US11186623B2 (en) | 2019-12-24 | 2021-11-30 | Akston Bioscience Corporation | Ultra-long acting insulin-Fc fusion proteins and methods of use |
| EP4126058A1 (en) * | 2020-03-31 | 2023-02-08 | Protomer Technologies Inc. | Conjugates for selective responsiveness to vicinal diols |
| CN116096733A (zh) | 2020-04-10 | 2023-05-09 | 阿卡斯通生物科学公司 | Covid-19融合蛋白的抗原特异性免疫疗法和使用方法 |
| US11192930B2 (en) | 2020-04-10 | 2021-12-07 | Askton Bioscences Corporation | Ultra-long acting insulin-Fc fusion protein and methods of use |
| US11198719B2 (en) | 2020-04-29 | 2021-12-14 | Akston Biosciences Corporation | Ultra-long acting insulin-Fc fusion protein and methods of use |
| JP2024500284A (ja) * | 2020-11-19 | 2024-01-09 | プロトマー・テクノロジーズ・インコーポレイテッド | 芳香族ホウ素含有化合物及びインスリン類似体 |
| US11667689B2 (en) | 2021-07-23 | 2023-06-06 | Akston Biosciences Corporation | Insulin-Fc fusion proteins and methods of use to treat cancer |
| JP2025506650A (ja) * | 2022-02-17 | 2025-03-13 | レボロ バイオセラピューティクス リミテッド | シャペロニン６０．１由来のペプチドを作製する方法 |
| WO2023225534A1 (en) | 2022-05-18 | 2023-11-23 | Protomer Technologies Inc. | Aromatic boron-containing compounds and related insulin analogs |
| WO2025117822A1 (en) * | 2023-11-28 | 2025-06-05 | University Of Notre Dame Du Lac | Glucose-triggered gelation of supramolecular peptide nanocoils with glucose-binding motifs |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6070100A (ja) * | 1983-09-26 | 1985-04-20 | Wako Pure Chem Ind Ltd | 新規ヒト型インシュリン誘導体，その製法，及びヒト型インシュリンの製造法 |
| DE3837825A1 (de) * | 1988-11-08 | 1990-05-10 | Hoechst Ag | Neue insulinderivate, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung |
| EP1453860A2 (en) * | 2001-12-02 | 2004-09-08 | Novo Nordisk A/S | Novel glucose-dependant insulins |
| US7317000B2 (en) * | 2001-12-02 | 2008-01-08 | Novo Nordisk A/S | Glucose-dependent insulins |
| US7928186B2 (en) * | 2006-08-02 | 2011-04-19 | Phoenix Pharmaceuticals, Inc. | Cell permeable bioactive peptide conjugates |
| CN102770153B (zh) * | 2010-02-22 | 2014-05-07 | 卡斯西部储备大学 | 呈可溶和结晶形式的长效胰岛素类似物制剂 |
| UA113626C2 (xx) * | 2011-06-02 | 2017-02-27 | Композиція для лікування діабету, що містить кон'югат інсуліну тривалої дії та кон'югат інсулінотропного пептиду тривалої дії | |
| US20160031962A1 (en) * | 2012-04-20 | 2016-02-04 | Kleomenis K. Barlos | Solid phase peptide synthesis of insulin using side chain achored lysine |
| WO2014093696A2 (en) * | 2012-12-12 | 2014-06-19 | Massachusetts Institute Of Technology | Insulin derivatives for diabetes treatment |
| WO2016179568A1 (en) * | 2015-05-06 | 2016-11-10 | Protomer Technologies, Inc. | Glucose responsive insulins |
-
2019
- 2019-04-15 EP EP19789533.7A patent/EP3781147A4/en not_active Withdrawn
- 2019-04-15 KR KR1020207032777A patent/KR20210005630A/ko not_active Ceased
- 2019-04-15 CA CA3097359A patent/CA3097359A1/en active Pending
- 2019-04-15 JP JP2020556885A patent/JP2021521230A/ja active Pending
- 2019-04-15 WO PCT/US2019/027484 patent/WO2019204206A1/en not_active Ceased
- 2019-04-15 CN CN201980031925.3A patent/CN112423741A/zh active Pending
- 2019-04-15 AU AU2019255611A patent/AU2019255611A1/en not_active Abandoned
- 2019-04-15 US US17/040,973 patent/US20210214412A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021521230A5 (https=) | ||
| EP1360202B1 (en) | Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders | |
| JPWO2019204206A5 (https=) | ||
| JP7596268B2 (ja) | グルカゴン、ｇｌｐ－１及びｇｉｐ受容体の全てに活性を有する三重活性体と、インスリンとを含む薬学組成物 | |
| JP2018515088A5 (https=) | ||
| JP7536030B2 (ja) | 増殖分化因子１５併用療法 | |
| TWI353250B (en) | Glp-1 pharmaceutical compositions | |
| US10822386B2 (en) | Insulin analogues with enhanced stability and reduced mitogenicity | |
| CN105324397A (zh) | 胰岛素-肠促胰岛素缀合物 | |
| JP2013501818A (ja) | 修飾された血管作動性腸管ペプチド | |
| EP2373681A1 (en) | Pharmaceutical compositions | |
| US20150299286A1 (en) | Glutamic acid-stabilized insulin analogues | |
| JP2017536337A5 (https=) | ||
| US20220235111A1 (en) | Variant Single-Chain Insulin Analogues | |
| JP2021533204A5 (https=) | ||
| CN107108716A (zh) | 双相性单链胰岛素类似物 | |
| JP2022551233A (ja) | 異なる構造のｇｌｐ－１アナログペプチド修飾二量体およびその調製方法のｉｉ型糖尿病の治療における用途 | |
| JP2017500316A5 (https=) | ||
| CN113105561B (zh) | 一种双靶点融合蛋白的制备方法和应用 | |
| WO2016172269A2 (en) | Insulin analogs having shortened b chain peptides and associated methods | |
| CN106279430B (zh) | Exendin‑4类似物融合蛋白及其制备方法和用途 | |
| JP2010043001A (ja) | Ｇｌｐ−１誘導体とその用途 | |
| JPH0338600A (ja) | Ｖｉｐ同族体 | |
| Linderoth et al. | GLP‐1 Receptor Agonists for the Treatment of Type 2 Diabetes and Obesity | |
| CN106146667B (zh) | 一种Exendin-4融合蛋白及其制备方法与用途 |